Aurobindo Pharma Limited

Mylan Laboratories Limited

Ranbaxy Laboratories, Inc.

Other

Natco Pharma Limited

Aurobind - Pharma Ltd.

Ramesh Dandala

Sivakumaran Meenakshisunderam

Meenakshisunderam Sivakumaran

Sukumar Nandi

Sambhu Prasad Sarma Mallela

Vijay Kumar Handa

Lakshmana Rao Vadali

Jag Mohan Khanna

Sureshbabu Jayachandra

Sonny Sebastian

Senthil Kumar Natarajan

Narayan K A S S Garimella

Gangadhar Bhima Shankar Nangi

Sunil Kumar Buridipadu

Srinivasa Rao V N Divvela

Venkaiah Chowdary Nannapaneni

Durga Prasad Konakanchi

Pulla Reddy Muddasani

Ram Chander Aryan

Vipin Kumar Kaushik

Shankar Reddy Budidet

Subba Reddy Danda

Rani Ananta

Umashankar Das

Jagan Mohan Reddy Sanapureddy

Arun Kumar Gupta

Divvela Venkata Naga Srinivasa Rao

Nagaraju Mittapelly

Somappa Somannavar Yallappa

Raja Babu Balusu

Naga Trinadhachari Ganala

Joseph Prabahar Koilpillai

Seshadri Rao Manukonda

Shankar Rama

Srinivasa Rao Dasari

Venkataiah Sunku

Venkata Lakshmi Upputuri

Srinivasu Kasa

Govardhana Phani Sharma Vemavarapu

Swamy Saidugari

Ravikanth Jaldu

Brajesh Kumar Sinha

Prabhakar Divya

Sunil Kumar Buridipad

Sivarama Prasad Vellanki

V Raghava Reddy Ambati

Srinivas Garaga

Gangadhar Bhima Shankar Nandi

Rajasekhar Ponduri

Venkata Vara Prasada Rao Korrapati

Rameshbabu Konda

Venkata Subramanyeswara Rao Inti

Mahesh Nagarimadugu

Subbarayudu Putta

Sankar Reddy Budidet

Venkata Kishore Gowrabathina

Lenin Racha

Bhaskar Rao Padala

Divvela Venkata Naga Srinvasa Rao

Koilpillai Joseph Prabahar

Sanapureddy Jagan Mohan Reddy

Ganagadnar Bhima Shankar Nangi

Gollapalli Venkateswara Rao

Nageshwara Rao Achanta

V V Prasada Rao Korrapati

Meenakhshisunderam Sivakumaran

Eswara Reddy Yerva

Sivaprasad Dorasala

Dandala Subramanyam

Seshari Rao Manukonda

Vijay Kumar Palla

Rao Potla Srinivasa

Krishna Ravi Vijaya

Srinivasa Rao Dasarl

Rao Manukonda Seshadri

Venkata Naga Srinivasa Rao Divvela

Naveen Kumar Podila

The present invention relates to a process for the preparation of high pure Eribulin and Eribulin Mesylate. The present invention involves preparation of high pure Eribulin and its mesylate salt involving chiral acid addition salts of Eribulin.

Process for the preparation of high pure Eribulin and its Mesylate salt

The present disclosure provides a process for the preparation of velpatasvir intermediates. The intermediates may be further converted to velpatasvir or pharmaceutically acceptable salts thereof.

Process for the preparation of velpatasvir

The present disclosure provides a process for the preparation a premix of raltegravir potassium form 3 with excipients. This premix may be used in the manufacture of pharmaceutical formulations containing raltegravir.

Premix of crystalline raltegravir potassium salt and a process for the preparation thereof

A process for the resolution of racemic 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulphonyl)-eth-2-ylamine using novel chiral salts is disclosed. An L-phenylalanine p-toluene-sulfonamide salt of (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulphonyl)-eth-2-ylamine and a di-p-toluoyl-L-tartaric acid salt of (S)-2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulphonyl)-eth-2-ylamine are also provided.

Process for the enantiomeric resolution of apremilast intermediates

The present disclosure provides crystalline piperidine sulfamoyl intermediates of formula 8 and 9. The present disclosure also relates to an improved process for the preparation of cobicistat using compounds of formulae 8 and 9. 

Preparation of cobicistat intermediates

The present invention relates to an improved process for the preparation of pure compound of Formula-II, which is an intermediate in the preparation of Aliskiren and further conversion of compound of Formula-II into Aliskiren or its pharmaceutically acceptable salts. 

Process for the preparation of aliskiren

The present invention relates to an improved process to prepare Rosuvastatin calcium of Formula (I), with good quality. Further, the present invention also relates to a crystalline polymorphic form of Rosuvastatin ethyl ester. 

Process for the manufacture of rosuvastatin calcium using crystalline rosuvastatin ethyl ester

An improved process for the preparation of (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole of Formula I, (I) with high enantiomeric excess from racemic mixture. 

Process for preparing an optically active proton pump inhibitor

The present invention relates to an improved process for preparing Rosuvastatin calcium of Formula I. 

Process for preparing rosuvastatin calcium

The present invention relates to the purification of (2S,3S,5S)-5-amino-2-N,N-dibenzylamino-3-hydroxy-1,6-diphenylhexane (III) by making its crystalline acid addition salt, which can be used as such to produce Lopinavir/Ritonavir with high purity and yield. Formula III 

Process for the preparation of substantially pure (2S,3S,5S)-5-amino-2-N,N-dibenzylamino-3-hydroxy-1,6-diphenylhexane

The present invention relates to an improved process for preparing (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid calcium of Formula (I). 

Process for preparation of rosuvastatin calcium field of the invention

An improved process for preparing 11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3&#x2032;-e][1,4]diazepin-6-one of Formula (I). 

Process for preparing nevirapine

The present invention relates to an improved process for preparing (2E)-3-[4-(4-fluorophenyl)-6-iso-propyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-propenal of Formula I which is an intermediate useful in the preparation of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoicacid]calcium salt of Formula II. 

The present invention relates to an improved process for the preparation of 2-n-butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1&#x2032;-biphenyl]-4-yl]-1,3-diazaspiro[4.4]non--en-4-one (Irbesartan).

Process for the preparation of Irbesartan

The present invention relates to an improved process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride of Formula I. 

Process for the preparation of donepezil hydrochloride

Growing community of inventors

Hyderabad Telangana, India

Ramesh Dandala